Biosafety data as confidential business information.

Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs.

Enregistré dans:
Détails bibliographiques
Auteur principal: Kaare M Nielsen
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2013
Sujets:
Accès en ligne:https://doaj.org/article/94e9c705bfe74588872bd00c8d05debe
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!